Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Surgical Endoscopy
Published in: Surgical Endoscopy 1/2017

01-01-2017

GERD and acid reduction medication use following gastric bypass and sleeve gastrectomy

Authors: Alex C. Barr, Matthew J. Frelich, Matthew E. Bosler, Matthew I. Goldblatt, Jon C. Gould

Published in: Surgical Endoscopy | Issue 1/2017

Login to get access

Abstract

Background

Gastroesophageal reflux disease is a common comorbid medical condition of obesity. Laparoscopic sleeve gastrectomy has been associated with de novo and worsening GERD following surgery. For this reason, patients who suffer from GERD and are considering bariatric surgery are often counseled to undergo gastric bypass. Given this practice, we sought to determine acid reduction medication (ARM) utilization in bariatric surgical patients who undergo one of these procedures prior to surgery and at 1 year following surgery.

Methods

A retrospective review of prospectively maintained data on patients to undergo gastric bypass or sleeve gastrectomy between November 2012 and December 2014 was conducted after IRB approval. ARM utilization and Gastroesophageal Reflux Disease Health-Related Quality of Life (GERD-HRQL) scores [range 0 (no symptoms)–50 (severe GERD)] were compared prior to surgery and at 1 year postoperatively.

Results

334 patients underwent an eligible procedure in the study interval. 147 patients (44 %) had data on both preoperative and 1 year postoperative ARM use (93 gastric bypass and 54 sleeve gastrectomy). ARM utilization prior to surgery in gastric bypass patients did not reach statistical significance when compared to sleeve gastrectomy (40.9 vs. 26 %, p = 0.07). GERD-HRQL scores were greater prior to surgery in gastric bypass patients (GERD-HRQL 8.2 vs. 1.9; p < 0.01). At 12 months postoperatively, sleeve gastrectomy patients had a significantly higher rate of overall ARM use (48.1 vs. 16.1 %, p < 0.01), new ARM use (35 vs. 7.3 %, p < 0.01), and persistent ARM use (78.6 vs. 21.9 %, p < 0.01) when compared to gastric bypass patients. GERD-HRQL scores were similar overall at 12 months postoperatively (4.4 bypass vs. 4.8 sleeve; p = 0.72).

Conclusion

Laparoscopic sleeve gastrectomy is associated with a significantly increased likelihood that acid reduction medications will be necessary for GERD symptom control 12 months postoperatively when compared to gastric bypass.
Literature
1.
Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J (2003) Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 290:66–72CrossRefPubMed
2.
3.
Huseini M, Wood GC, Seiler J, Argyropoulos G, Irving BA, Gerhard GS, Benotti P, Still C, Rolston DD (2014) Gastrointestinal symptoms in morbid obesity. Front Med 1:1–7CrossRef
4.
Pallati PK, Shaligram A, Shostrom VK, Oleynikov D, McBride CL, Goede MR (2014) Improvement in gastroesophageal reflux disease symptoms after various bariatric procedures: review of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis 10:502–507CrossRefPubMed
5.
Madalosso CA, Gurski RR, Callegari-Jacques SM, Navarini D, Mazinni G, Pereira Mda S (2016) The impact of gastric bypass on gastroesophageal reflux disease in morbidly obese patients. Ann Surg 263(1):110–116CrossRefPubMed
6.
DuPree CE, Blair K, Steele SR, Martin MJ (2014) Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease: a national analysis. JAMA Surg 149(4):328–334CrossRefPubMed
7.
8.
Lois AW, Frelich MJ, Goldblatt MI, Wallace JR, Gould JC (2015) Gastrojejunostomy technique and anastomotic complications in laparoscopic gastric bypass. Surg Obes Relat Dis 11(4):808–813CrossRefPubMed
9.
Velanovich V (2007) The development of the GERD-HRQL symptom severity instrument. Dis Esophagus 20(2):130–134CrossRefPubMed
10.
Ponce J, Nguyen NT, Hutter M, Sudan R, Morton JM (2015) American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in the United States, 2011–2014. Surg Obes Relat Dis 11(6):1199–1200CrossRefPubMed
11.
Friedenberg FK, Xanthopoulos M, Foster GD, Richter JE (2008) The association between gastroesophageal reflux disease and obesity. Am J Gastroenterol 103(8):2111–2122CrossRefPubMed
12.
Frezza EE, Ikramuddin S, Gourash W, Rakitt T, Kingston A, Luketich J, Schauer P (2002) Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass. Surg Endosc 16:1027–1031CrossRefPubMed
13.
Mejia-Rivas MA, Herrera-Lopez A, Hernandez-Calleros J, Hererra MF, Valdovinos MA (2008) Gastroesophageal reflux disease in morbid obesity: the effect of Roux-en-Y gastric bypass. Obes Surg 18:1217–1224CrossRefPubMed
14.
Tutuian R (2011) Obesity and GERD: pathophysiology and effect of bariatric surgery. Curr Gastroenterol Rep 13(3):205–212CrossRefPubMed
15.
Smith CD, Herkes SB, Behrns KE, Fairbanks VF, Kelly KA, Sarr MG (1993) Gastric acid secretion and vitamin B12 absorption after vertical Roux-en-Y gastric bypass for morbid obesity. Ann Surg 218(1):91–96CrossRefPubMedPubMedCentral
16.
Madalosso CA, Gurski RR, Callegari-Jacques SM, Navarini D, Thiesen V, Fornari F (2010) The impact of gastric bypass on gastroesophageal reflux disease in patients with morbid obesity: a prospective study based on the Montreal Consensus. Ann Surg 251(2):244–248CrossRefPubMed
17.
Vivek N, Prachand VN, Alverdy JC (2010) Gastroesophageal reflux disease and severe obesity: fundoplication or bariatric surgery? World J Gastroenterol 16(30):3757–3761CrossRef
18.
Pagé MP, Kastenmeier A, Goldblatt M, Frelich M, Bosler M, Wallace J, Gould J (2014) Medically refractory gastroesophageal reflux disease in the obese: what is the best surgical approach? Surg Endosc 28(5):1500–1504CrossRefPubMed
19.
20.
Oor JE, Roks DJ, Ünlü Ç, Hazebroek EJ (2016) Laparoscopic sleeve gastrectomy and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Surg 211(1):250–267CrossRefPubMed
21.
Klaus A, Weiss H (2008) Is preoperative manometry in restrictive bariatric procedures necessary? Obes Surg 18(8):1039–1042CrossRefPubMed
22.
Toro JP, Lin E, Patel AD, Davis SS Jr, Sanni A, Urrego HD, Sweeney JF, Srinivasan JK, Small W, Mittal P, Sekhar A, Moreno CC (2014) Association of radiographic morphology with early gastroesophageal reflux disease and satiety control after sleeve gastrectomy. J Am Coll Surg 219(3):430–438CrossRefPubMed
23.
Daes J, Jimenez ME, Said N, Daza JC, Dennis R (2012) Laparoscopic sleeve gastrectomy: symptoms of gastroesophageal reflux can be reduced by changes in surgical technique. Obes Surg 22(12):1874–1879CrossRefPubMedPubMedCentral
24.
Soricelli E, Iossa A, Casella G, Abbatini F, Cali B, Basso N (2012) Sleeve gastrectomy and crural repair in obese patients with gastroesophageal reflux disease and/or hiatal hernia. Surg Obes Relat Dis 9(3):356–361CrossRefPubMed
25.
Tai CM, Huang CK, Lee YC, Chang CY, Lee CT, Lin JT (2013) Increase in gastroesophageal reflux disease symptoms and erosive esophagitis 1 year after laparoscopic sleeve gastrectomy among obese adults. Surg Endosc 27(4):1260–1266CrossRefPubMed
26.
Che F, Nguyen B, Cohen A, Nguyen NT (2013) Prevalence of hiatal hernia in the morbidly obese. Surg Obes Relat Dis 9(6):920–924CrossRefPubMed
27.
28.
Li JF, Lai DD, Lin ZH, Jiang TY, Zhang AM, Dai JF, Li J, Lai D, Lin Z, Jiang T, Zhang A, Dai J (2014) Comparison of the long-term results of Roux-en-Y gastric bypass and sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis of randomized and nonrandomized trials. Surg Laparosc Endosc Percutan Tech 24(1):1–11CrossRefPubMed
29.
Varaban OA, Hawasli AA, Am Carlin, Genaw JA, English W, Dimick JB, Wood MH, Birkmeyer JD, Birkmeyer NJ, Finks JF (2015) Variation in utilization of acid reducing medication at 1 year following bariatric surgery: results from the Michigan Bariatric Surgery Collaborative. Surg Obes Relat Dis 11(1):222–228CrossRef
30.
Heidelbaugh JJ, Goldberg KL, Inadomi JM (2010) Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting. Am J Manag Care 16(9):e228–e234PubMed
31.
Thompson SK, Jamieson GG, Myers JC, Chin KF, Watson DI, Devitt PG (2007) Recurrent heartburn after laparoscopic fundoplication is not always recurrent reflux. J Gastrointest Surg 11(5):642–647CrossRefPubMed
Metadata
Title
GERD and acid reduction medication use following gastric bypass and sleeve gastrectomy
Authors
Alex C. Barr
Matthew J. Frelich
Matthew E. Bosler
Matthew I. Goldblatt
Jon C. Gould
Publication date
01-01-2017
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 1/2017
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-016-4989-4

Other articles of this Issue 1/2017

Surgical Endoscopy 1/2017 Go to the issue

OriginalPaper

Current training on the basics of robotic surgery in the Netherlands: Time for a multidisciplinary approach?

OriginalPaper

The incidence and locational predilection of metachronous tumors after endoscopic resection of high-grade dysplasia and early gastric cancer

New Technology

A novel retractable laparoscopic device for mapping gastrointestinal slow wave propagation patterns

OriginalPaper

Surgical flow disturbances in dedicated minimally invasive surgery suites: an observational study to assess its supposed superiority over conventional suites

Erratum

Erratum to: Warmed and humidified carbon dioxide for abdominal laparoscopic surgery: meta-analysis of the current literature

OriginalPaper

Effect of bag extraction to prevent wound infection on umbilical port site wound on elective laparoscopic cholecystectomy: a prospective randomised clinical trial